MAX Chat
Company Analysis Altimmune, Inc.
1. Summary
Advantages
- The stock's return over the last year (6.79%) is higher than the sector average (-0.4713%).
- Current debt level 1.21% is below 100% and has decreased over 5 years from 3.23%.
Disadvantages
- Price (6.92 $) is higher than fair price (6.75 $)
- Dividends (0%) are below the sector average (0.527%).
- The company's current efficiency (ROE=-59.86%) is lower than the sector average (ROE=14.17%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Altimmune, Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 16.3% | -41.7% | 1% |
| 90 days | 66.3% | 3.4% | 24.5% |
| 1 year | 6.8% | -0.5% | 21.2% |
ALT vs Sector: Altimmune, Inc. has outperformed the "Healthcare" sector by 7.26% over the past year.
ALT vs Market: Altimmune, Inc. has significantly underperformed the market by -14.43% over the past year.
Slightly volatile price: ALT is more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: ALT with weekly volatility of 0.1306% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (6.92 $) is higher than the fair price (6.75 $).
Price is higher than fair: The current price (6.92 $) is 2.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (1.82) is lower than that of the sector as a whole (64.15).
P/E vs Market: The company's P/E (1.82) is lower than that of the market as a whole (90.03).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.21) is lower than that of the sector as a whole (18.96).
P/BV vs Market: The company's P/BV (4.21) is lower than that of the market as a whole (9.39).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (25987.24) is higher than that of the sector as a whole (32.77).
P/S vs Market: The company's P/S indicator (25987.24) is higher than that of the market as a whole (10.12).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-5.11) is lower than that of the sector as a whole (274.79).
EV/Ebitda vs Market: The company's EV/Ebitda (-5.11) is lower than that of the market as a whole (50.91).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 18.76% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (18.76%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-15.75%).
5.4. ROE
ROE vs Sector: The company's ROE (-59.86%) is lower than that of the sector as a whole (14.17%).
ROE vs Market: The company's ROE (-59.86%) is lower than that of the market as a whole (11.64%).
5.5. ROA
ROA vs Sector: The company's ROA (-54.33%) is lower than that of the sector as a whole (1.18%).
ROA vs Market: The company's ROA (-54.33%) is lower than that of the market as a whole (6.89%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (7.63%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.08%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '0.527%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.67.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
